Publikationen

Sharifan, A.; Harrod, C.; Dobrescu, A.; Gartlehner, G. (2026). Reverse fragility index shows high fragility in Cochrane meta-analyses with P values between 0.05 and 0.20: a meta-epidemiological study. Journal of Clinical Epidemiology, 195: https://doi.org/10.1016/j.jclinepi.2026.112285

Ledinger, D.; Todhunter-Brown, A.; Smith, M., Griebler, U.; Pollock, D.; Rees, R.; Tricco, A.C.; Dawson, S.; Macura, B.; Staniszewska, S.; Boddy, K.; Gartlehner, G.; Nussbaumer-Streit, B. (2026). Top 20 research priorities on methods of coproduction in evidence synthesis. Journal of Clinical Epidemiology, 195: https://doi.org/10.1016/j.jclinepi.2026.112286

GBD 2023 Maternal Mortality Collaborators; Sharifan, A. (2026). Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990–2023: a systematic analysis for the Global Burden of Disease Study 23. Lancet Obstet Gynaecol Womens Health, 2 (5): e375-e424

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators; Sharifan, A. (2026). Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Neurology, 25(5): P451-468

Braun, A.; Angerer, S.; Latzke, M. (2026). Structural social capital and cognitive decline in Europe: longitudinal evidence from the Survey of Health, Ageing and Retirement in Europe. Aging & Mental Health, https://doi.org/10.1080/13607863.2026.2672101: 1–14

Helfer, B.; Henke-Ciazynska, K.; Boyle, R.J. (2026). Operation Stork Speed represents an opportunity to reform infant formula clinical trials. Nature Food, https://doi.org/10.1038/s43016-026-01357-6: https://doi.org/10.1038/s43016-026-01357-6

GBD 2023 Iran Collaborators; Sharifan, A.; et. al. (2026). Burden of 292 causes of death and life expectancy decomposition in Iran, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, 14(5): e734-e748

Sharifan, A.; Gadinger, A.; Cooper, C.; Braun, A. (2026). Vitrectomy After Cataract Surgery as a Patient Safety Indicator: A Rapid Review to Support Benchmarking Within the Austrian Inpatient Quality Indicators Framework. Journal of Patient Safety, 10.1097: 1-11

Affengruber, L.; Emprechtinger, R.; Persad, E.; Kleijnen, J.; Gartlehner, G. (2026). Characteristics of studies falsely excluded during single-reviewer abstract screening: a meta-epidemiological analysis. BMC Medical Research Methodology, 26:117: https://doi.org/10.1186/s12874-026-02838-9

Sharifan, A.; Dobrescu, A.I.; Klerings, I.; Gartlehner, G. (2026). Update Alert 4: Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-26-00504.

Moser, T.K.; Dobrescu, A.I.; Sommer, I.; Goeschl, S.; Sharifan, A.; Ledinger, D.; Klerings, I.; Gartlehner, G. (2026). Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-05536.

GBD 2021 AEMT Collaborators; Sharifan, A. (2026). Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. Korean J Intern Med, 41(2): 350-366

GBD 2023 Breast Cancer Collaborators; Sharifan, A. (2026). Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Oncology, Volume 27, Issue 3: 302-326

GBD 2023 IHD & Dietary Risk Factors Collaborators; Sharifan, A. (2026). Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study. Nature Medicine, 32: 1454-1478

Sommer, I. Dobrescu, A. Gadinger, A. Sharifan, A. Pinte, L. Fangmeyer, M. Klerings, I. Gartlehner, G. (2026). Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians (Version 3). Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-03691.

Sharifan, A. (2026). Misrepresentation of nonsignificant results: reporting pitfalls in urology randomised trials. BJU International, https://doi.org/10.1111/bju.70139: https://doi.org/10.1111/bju.70139

Griebler, U.; Ledinger, D.; Klerings, I.; Schandelmaier, S.; Dobrescu, A.; Deschodt, M.; McLennan, S.; Hemkens, L.G.; Nussbaumer-Streit, B.; Briel, M. (2026). Identifying prior evidence for new trials (REVEAL): guidance for clinical researchers. BMJ, 392:e083718: 10.1136/ bmj-2024-08

Affengruber, L.; Grillich, L.; Schultes, M.T.; Sommer, I. (2026). Evaluation of “Sport for the Strong” – A project for the integration of children and adolescents with special educational needs into club sports. Evaluating and Program Planning, 114: 102700

Dobrescu, A.I.; Pinte, L.; Sharifan, A.; Gadinger, A.; Moser, I.; Cooper, C.; Gartlehner, G. (2026). Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-05044.

Jahn, B.; Sroczynski, G.; Santamaria, J.; Rochau, U.; Siebert, S.; Mühlberger, N.; Puntscher, S.; Ferlitsch, M.; Hackl, M.; Tilg, H.; Renner, F.; Gschwantler, M.; Schiller-Fruehwirth, I.; Fischer, T.; Bachler, H.; Fröschl, B.; Dietscher, C.; Schernhammer, E.; Gartlehner, G.; Siebert, U.; (2026). Evidence-based decision analysis guiding clinical guidelines for an organized population-based screening for colorectal cancer. Best Practice & Research Clinical Gastroenterology, 80: 102045